Domov › Sladkorna bolezen tipa 1 › Washington
Klinične študije za Sladkorna bolezen tipa 1 v Washington
20 študij za Sladkorna bolezen tipa 1 išče udeležence na lokacijah v Washington.
Mesta v Washington
Uradno besedilo študije (angleško)
Type 1 Diabetes Extension Study
- Benaroya Research Institute, Seattle
Vključevanje udeležencevOpazovalna študija
Starost 8–35 · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT02734277METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Vključevanje udeležencevFaza 2
Starost 18–69 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07699380A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason- Site Number : 8400038, Seattle
- MultiCare Mary Bridge Children's Health Center- Site Number : 8400037, Tacoma
Vključevanje udeležencevFaza 3
Starost 1–25 · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- Benaroya Research Institute, Seattle
- University of Washington Diabetes Institute, Seattle
Vključevanje udeležencevFaza 1/2
Starost 12–35 · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT06783309Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- Benaroya Research Institute, Seattle
Vključevanje udeležencevFaza 2
Starost 4–34 · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07216391Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- Benaroya Research Institute, Seattle
Vključevanje udeležencevFaza 2
Starost 8–45 · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT07142252A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
- Seattle Children's Hospital, Seattle
Vključevanje udeležencevFaza 1/2
Starost 9–20 · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT07061574SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
- Benaroya Research Institute at Virginia Mason, Seattle
- Mary Bridge Children's Outpatient Center - Tacoma, Tacoma
Vključevanje udeležencevFaza 2
Starost 5–40 · Vsi spoli · Posodobljeno 24. avg. 2026 · NCT07187531Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery
- University of Washington, Seattle
Vključevanje udeležencev
Starost 18–65 · Vsi spoli · Posodobljeno 16. jul. 2026 · NCT06880835Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 2. jun. 2026 · NCT05822609Kidney Precision Medicine Project
- University of Washington, Seattle
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 14. apr. 2026 · NCT04334707Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM
- Rainier Clinical Reseach Center, Renton
Vključevanje udeležencev
Starost 18–65 · Vsi spoli · Posodobljeno 9. apr. 2026 · NCT07296276Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
- Rainier Clinical Research Center, Renton
Vključevanje udeležencevFaza 2
Starost 18–50 · Vsi spoli · Posodobljeno 6. apr. 2026 · NCT06964087Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
Vključevanje udeležencevFaza 3
Starost 18–75 · Vsi spoli · Posodobljeno 24. mar. 2026 · NCT06217302Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
Vključevanje udeležencevFaza 3
Starost 18–49 · Vsi spoli · Posodobljeno 4. mar. 2026 · NCT05819138Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.
- Seattle Children's, Seattle
Vključevanje udeležencev
Starost 16–19 · Vsi spoli · Posodobljeno 30. dec. 2025 · NCT07292558EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
- Benaroya Research Institute, Seattle
Vključevanje udeležencevOpazovalna študija
Do 70 let · Vsi spoli · Posodobljeno 19. dec. 2025 · NCT03369821InvesT1D: Promoting Adolescent Investment in Diabetes Care
- Seattle Children's, Seattle
Vključevanje udeležencev
Starost 12 in več · Vsi spoli · Posodobljeno 16. dec. 2025 · NCT06384911TrialNet Pathway to Prevention of T1D
- Benaroya Research Institute, Seattle
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 2–45 · Vsi spoli · Posodobljeno 1. jul. 2025 · NCT00097292MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Seattle Children's Hospital, Seattle
Vključevanje udeležencevFaza 1
Starost 12–25 · Vsi spoli · Posodobljeno 13. jun. 2025 · NCT05065372Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.